We have collected compelling evidence from several independent data sets that high HOTAIRM1 expression is linked to clinical aggressiveness and shorter survival of glioblastoma patients and that gene copy number gain is a likely cause of increased HOTAIRM1 expression levels in glioblastoma. This evidence concerns the gene HOTAIRM1 and glioblastoma.